132 related articles for article (PubMed ID: 9350483)
1. Causes and consequences of hyperhomocyst(e)inemia.
Pietrzik K; Brönstrup A
Int J Vitam Nutr Res; 1997; 67(5):389-95. PubMed ID: 9350483
[TBL] [Abstract][Full Text] [Related]
2. [Hyperhomocyst(e)inemia--an independent risk factor of stroke].
Lalouschek W; Aull S; Deecke L; Schnider P; Uhl F; Zeiler K
Fortschr Neurol Psychiatr; 1996 Jul; 64(7):271-7. PubMed ID: 8765893
[TBL] [Abstract][Full Text] [Related]
3. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia.
Kang SS; Wong PW
Atherosclerosis; 1996 Jan; 119(2):135-8. PubMed ID: 8808490
[TBL] [Abstract][Full Text] [Related]
4. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.
Moghadasian MH; McManus BM; Frohlich JJ
Arch Intern Med; 1997 Nov; 157(20):2299-308. PubMed ID: 9361570
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.
Ducloux D; Fournier V; Rebibou JM; Bresson-Vautrin C; Gibey R; Chalopin JM
Clin Nephrol; 1998 Apr; 49(4):232-5. PubMed ID: 9582553
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
Böger RH; Bode-Böger SM; Sydow K; Heistad DD; Lentz SR
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocyst(e)inemia--determining factors and treatment.
Genest J
Can J Cardiol; 1999 Apr; 15 Suppl B():35B-38B. PubMed ID: 10350684
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocyst(e)inemia: is this a novel risk factor in hypertension?
Virdis A; Ghiadoni L; Salvetti G; Versari D; Taddei S; Salvett A
J Nephrol; 2002; 15(4):414-21. PubMed ID: 12243373
[TBL] [Abstract][Full Text] [Related]
10. Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.
Lentz SR; Malinow MR; Piegors DJ; Bhopatkar-Teredesai M; Faraci FM; Heistad DD
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2930-4. PubMed ID: 9409278
[TBL] [Abstract][Full Text] [Related]
11. Homocyst(e)ine, vitamins and genetic interactions in vascular disease.
Malinow MR
Can J Cardiol; 1999 Apr; 15 Suppl B():31B-34B. PubMed ID: 10350683
[TBL] [Abstract][Full Text] [Related]
12. Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate.
Henning BF; Zidek W; Riezler R; Graefe U; Tepel M
Res Exp Med (Berl); 2001 Mar; 200(3):155-68. PubMed ID: 11426667
[TBL] [Abstract][Full Text] [Related]
13. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.
Sydow K; Schwedhelm E; Arakawa N; Bode-Böger SM; Tsikas D; Hornig B; Frölich JC; Böger RH
Cardiovasc Res; 2003 Jan; 57(1):244-52. PubMed ID: 12504835
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
Stühlinger MC; Stanger O
Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocyst(e)inemia in chronic stable renal transplant patients.
Machado DJ; Paula FJ; Sabbaga E; Ianhez LE
Rev Hosp Clin Fac Med Sao Paulo; 2000; 55(5):161-8. PubMed ID: 11175576
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.
Langman LJ; Ray JG; Evrovski J; Yeo E; Cole DE
Arch Intern Med; 2000 Apr; 160(7):961-4. PubMed ID: 10761961
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.
Falcon CR; Cattaneo M; Panzeri D; Martinelli I; Mannucci PM
Arterioscler Thromb; 1994 Jul; 14(7):1080-3. PubMed ID: 8018663
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocyst(e)inemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives.
Beaumont V; Malinow MR; Sexton G; Wilson D; Lemort N; Upson B; Beaumont JL
Atherosclerosis; 1992 Jun; 94(2-3):147-52. PubMed ID: 1632868
[TBL] [Abstract][Full Text] [Related]
19. Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia.
Yoo JH; Choi GD; Kang SS
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1921-5. PubMed ID: 10938012
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hyperhomocyst(e)inemia: physiological basis.
Kang SS
J Nutr; 1996 Apr; 126(4 Suppl):1273S-5S. PubMed ID: 8642469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
